Arizona Republic reports MindCrowd goal of 1 million participants

Monday, June 24, 2013

This article in the Arizona Republic explains Dr. Huentelman's vision for MindCrowd and how scientists are going to use the test results to help find a cure for Alzheimer's.

"Before we can discover new treatments for brain-related diseases such as Alzheimer's and Parkinson's, we need to understand the human genetic blueprint - DNA - that determines how the brain works in healthy individuals," he (Huentelman) said. "Then, we will be better equipped to develop new medicines and therapies for individuals with brain disorders."

Read the article here.